Calcium and CaSR/IP3R in prostate cancer development

Abstract Prostate cancer (PrCa) progression and mortality are associated with calcium metabolism, parathyroid hormone level, and vitamin D level. However, the lack of comprehensive understanding on the molecular rationale of calcium intake, serum homeostasis, and cytoplasmic function, is critically...

Full description

Bibliographic Details
Main Authors: Liyang Wang, MengMeng Xu, Zhongguang Li, Mengting Shi, Xin Zhou, Xinnong Jiang, Joseph Bryant, Steven Balk, Jianjie Ma, William Isaacs, Xuehong Xu
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Cell & Bioscience
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13578-018-0217-3
_version_ 1818941075588382720
author Liyang Wang
MengMeng Xu
Zhongguang Li
Mengting Shi
Xin Zhou
Xinnong Jiang
Joseph Bryant
Steven Balk
Jianjie Ma
William Isaacs
Xuehong Xu
author_facet Liyang Wang
MengMeng Xu
Zhongguang Li
Mengting Shi
Xin Zhou
Xinnong Jiang
Joseph Bryant
Steven Balk
Jianjie Ma
William Isaacs
Xuehong Xu
author_sort Liyang Wang
collection DOAJ
description Abstract Prostate cancer (PrCa) progression and mortality are associated with calcium metabolism, parathyroid hormone level, and vitamin D level. However, the lack of comprehensive understanding on the molecular rationale of calcium intake, serum homeostasis, and cytoplasmic function, is critically hindering our ability to propose a mechanism based technique for targeting calcium in PrCa. Recently, studies performed on PrCa samples have shown that calcium-sensing receptor regulates cytoplasmic calcium levels in relation to extracellular calcium concentrations. Recent publications have also revealed the role of BAP1 and FBXL2 associated endoplasmic reticular IP3Rs in controlling the trafficking of calcium from cytosol into the mitochondria of PrCa cells. Competitive binding between BAP1, PTEN and FBXL2 to IP3Rs regulates the calcium flux of mitochondria and thereby controls apoptosis. Analysis of data released by Prostate Adenocarcinoma (Provisional TCGA) reveals that calcium related proteins play critical role in the development of PrCa. From this constantly expanding appreciation for the role of calcium outside the muscle, we predict that calcium-induced-calcium-release ryanodine receptors could also be involved in determining cell fate.
first_indexed 2024-12-20T06:49:46Z
format Article
id doaj.art-c52901e7dfde4a8d9bd78794218257f8
institution Directory Open Access Journal
issn 2045-3701
language English
last_indexed 2024-12-20T06:49:46Z
publishDate 2018-02-01
publisher BMC
record_format Article
series Cell & Bioscience
spelling doaj.art-c52901e7dfde4a8d9bd78794218257f82022-12-21T19:49:36ZengBMCCell & Bioscience2045-37012018-02-01811710.1186/s13578-018-0217-3Calcium and CaSR/IP3R in prostate cancer developmentLiyang Wang0MengMeng Xu1Zhongguang Li2Mengting Shi3Xin Zhou4Xinnong Jiang5Joseph Bryant6Steven Balk7Jianjie Ma8William Isaacs9Xuehong Xu10National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life SciencesDepartment of Pharmacology, Duke University Medical CenterNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life SciencesNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life SciencesNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life SciencesCollege of Life Science and Technology, Huazhong University of Science and TechnologyInstitute of Human Virology, University of Maryland School of MedicineHematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolOhio State University School of MedicineJohns Hopkins School of MedicineNational Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life SciencesAbstract Prostate cancer (PrCa) progression and mortality are associated with calcium metabolism, parathyroid hormone level, and vitamin D level. However, the lack of comprehensive understanding on the molecular rationale of calcium intake, serum homeostasis, and cytoplasmic function, is critically hindering our ability to propose a mechanism based technique for targeting calcium in PrCa. Recently, studies performed on PrCa samples have shown that calcium-sensing receptor regulates cytoplasmic calcium levels in relation to extracellular calcium concentrations. Recent publications have also revealed the role of BAP1 and FBXL2 associated endoplasmic reticular IP3Rs in controlling the trafficking of calcium from cytosol into the mitochondria of PrCa cells. Competitive binding between BAP1, PTEN and FBXL2 to IP3Rs regulates the calcium flux of mitochondria and thereby controls apoptosis. Analysis of data released by Prostate Adenocarcinoma (Provisional TCGA) reveals that calcium related proteins play critical role in the development of PrCa. From this constantly expanding appreciation for the role of calcium outside the muscle, we predict that calcium-induced-calcium-release ryanodine receptors could also be involved in determining cell fate.http://link.springer.com/article/10.1186/s13578-018-0217-3Prostate cancerCaSRRyRIP3RBAP1FBXL2
spellingShingle Liyang Wang
MengMeng Xu
Zhongguang Li
Mengting Shi
Xin Zhou
Xinnong Jiang
Joseph Bryant
Steven Balk
Jianjie Ma
William Isaacs
Xuehong Xu
Calcium and CaSR/IP3R in prostate cancer development
Cell & Bioscience
Prostate cancer
CaSR
RyR
IP3R
BAP1
FBXL2
title Calcium and CaSR/IP3R in prostate cancer development
title_full Calcium and CaSR/IP3R in prostate cancer development
title_fullStr Calcium and CaSR/IP3R in prostate cancer development
title_full_unstemmed Calcium and CaSR/IP3R in prostate cancer development
title_short Calcium and CaSR/IP3R in prostate cancer development
title_sort calcium and casr ip3r in prostate cancer development
topic Prostate cancer
CaSR
RyR
IP3R
BAP1
FBXL2
url http://link.springer.com/article/10.1186/s13578-018-0217-3
work_keys_str_mv AT liyangwang calciumandcasrip3rinprostatecancerdevelopment
AT mengmengxu calciumandcasrip3rinprostatecancerdevelopment
AT zhongguangli calciumandcasrip3rinprostatecancerdevelopment
AT mengtingshi calciumandcasrip3rinprostatecancerdevelopment
AT xinzhou calciumandcasrip3rinprostatecancerdevelopment
AT xinnongjiang calciumandcasrip3rinprostatecancerdevelopment
AT josephbryant calciumandcasrip3rinprostatecancerdevelopment
AT stevenbalk calciumandcasrip3rinprostatecancerdevelopment
AT jianjiema calciumandcasrip3rinprostatecancerdevelopment
AT williamisaacs calciumandcasrip3rinprostatecancerdevelopment
AT xuehongxu calciumandcasrip3rinprostatecancerdevelopment